Cargando…

Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?

BACKGROUND: To evaluate surgical outcome and survival benefit after quaternary cytoreduction (QC) in epithelial ovarian cancer (EOC) relapse. METHODS: We systematically evaluated all consecutive patients undergoing QC in our institution over a 12-year period (October 2000–January 2012). All relevant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fotopoulou, C, Savvatis, K, Kosian, P, Braicu, I E, Papanikolaou, G, Pietzner, K, Schmidt, S-C, Sehouli, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553531/ https://www.ncbi.nlm.nih.gov/pubmed/23321509 http://dx.doi.org/10.1038/bjc.2012.544

Ejemplares similares

ASO Author Reflections: Value of Cytoreduction in Extensive Ovarian Cancer—Does Surgical Effort Still Matter?
por: Fotopoulou, Christina
Publicado: (2019)

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers
por: Braicu, E-I, et al.
Publicado: (2011)

Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome
por: Hall, Marcia, et al.
Publicado: (2019)

Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
por: Fotopoulou, Christina, et al.
Publicado: (2012)

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort
por: Zang, R Y, et al.
Publicado: (2011)

Quaternary and beyond cytoreduction: An updated and expanded analysis
por: Manning-Geist, Beryl L., et al.
Publicado: (2021)

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer
por: Woopen, Hannah, et al.
Publicado: (2014)

Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters
por: Xiao, Yao, et al.
Publicado: (2023)

Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery(∗): A Prospective Substudy of a Randomized Controlled Trial
por: Hunsicker, Oliver, et al.
Publicado: (2015)

Cytoreductive Nephrectomy: Still Necessary in 2021
por: Méjean, Arnaud, et al.
Publicado: (2022)

How to predict treatment failure in frail patients with advanced epithelial ovarian cancer: strategies to personalize surgical effort
por: Fotopoulou, Christina
Publicado: (2019)

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
por: Nasser, Sara, et al.
Publicado: (2022)

Trends in extent of surgical cytoreduction for patients with ovarian cancer
por: Wong, Deanna H., et al.
Publicado: (2021)

Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case report
por: Passler, Mona, et al.
Publicado: (2019)

Maximal Effort Cytoreduction in Epithelial Ovarian Cancer: Perioperative Complications and Survival Outcomes from a Retrospective Cohort
por: Haidopoulos, Dimitrios, et al.
Publicado: (2023)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Role of aggressive surgical cytoreduction in advanced ovarian cancer
por: Chang, Suk-Joon, et al.
Publicado: (2015)

Does science still matter? The evolution of doubts
por: Broad, W J, et al.
Publicado: (2004)

The Serum Glycome to Discriminate between Early-Stage Epithelial Ovarian Cancer and Benign Ovarian Diseases
por: Biskup, Karina, et al.
Publicado: (2014)

Sialic Acid Linkage Analysis Refines the Diagnosis of Ovarian Cancer
por: Dědová, Tereza, et al.
Publicado: (2019)

A Still Greater Effort Required
Publicado: (1921)

Biological Impact of Unilateral Oophorectomy: Does the Number of Ovaries Really Matter?
por: Gasparri, Maria Luisa, et al.
Publicado: (2021)

Predicting incomplete cytoreduction in patients with advanced ovarian cancer
por: Egger, Eva K., et al.
Publicado: (2022)

Traditional Systemic Treatment Options in Advanced Low-Grade Serous Ovarian Cancer after Successful Cytoreduction: A Systematic Review and Meta-Analysis
por: Montero-Macías, Rosa, et al.
Publicado: (2022)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
por: Renner, Alex, et al.
Publicado: (2019)

Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients
por: Armbrust, R., et al.
Publicado: (2021)

When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place?
por: Martinek, Igor E., et al.
Publicado: (2010)

Correction to: Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients
por: Armbrust, R., et al.
Publicado: (2021)

Impact of brief prewarming on anesthesia-related core-temperature drop, hemodynamics, microperfusion and postoperative ventilation in cytoreductive surgery of ovarian cancer: a randomized trial
por: Kaufner, L., et al.
Publicado: (2019)

Does the surgeon matter in the management of ovarian cancer?
por: Chan, K K
Publicado: (1999)

Laparoscopic Cytoreduction for Primary Advanced Ovarian Cancer
por: Fanning, James, et al.
Publicado: (2010)

Chondroitin Sulfate Disaccharides, a Serum Marker for Primary Serous Epithelial Ovarian Cancer
por: Biskup, Karina, et al.
Publicado: (2021)

Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer—An Analysis of the NOGGO/JAGO
por: Heublein, Sabine, et al.
Publicado: (2023)

Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
por: Pellerino, Alessia, et al.
Publicado: (2023)

Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer
por: Wieczorek, Marta, et al.
Publicado: (2020)

Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute
por: Marszalek, Anne, et al.
Publicado: (2010)

Prof. Arthur Sagalowsky: cytoreductive nephrectomy is still important for advanced/metastatic renal cell cancer but many still need to be proved
por: Gao, Skylar
Publicado: (2016)

Checkpoint-inhibition in ovarian cancer: rising star or just a dream?
por: Pietzner, Klaus, et al.
Publicado: (2018)

Prolonged survival following maximal cytoreductive effort for peritoneal metastases from recurrent granulosa cell tumor of the ovary
por: Chua, Terence C., et al.
Publicado: (2011)

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
por: Carbajal-Mamani, Semiramis L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u0omicepgctd7s0a37u3o7159b